Fred Saad C

The impact of time to local tumor destruction on cancer-specific mortality in pT1a renal cell carcinoma

Objective: To evaluate the impact of time to local tumor destruction > 6 months on cancer-specific mortality in patients with pT1a renal cell carcinoma. Methods: Using the Surveillance, Epidemiology, and End Results database (2004–2022), patients with pT1aN0M0 renal cell carcinom...

Survival outcomes with Lutetium-177-PSMA-617 in metastatic castration-resistant prostate cancer patient according to baseline tumor characteristics

Abstract Purpose To investigate cancer-control outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients receiving Lutetium-177 Prostate-Specific Membrane Antigen-617 (Lu-177-PSMA) radioligand therapy according to initial baseline tumor characteristics. Methods...